• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首发重性抑郁障碍患者住院期间代谢综合征的患病率及相关因素分析。

Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients.

机构信息

Department of Psychiatry, Wuhan Mental Health Center, No. 89, Gongnongbing Road, Wuhan, Hubei Province, China.

Wuhan Hospital for Psychotherapy, Wuhan, China.

出版信息

Sci Rep. 2023 Sep 19;13(1):15496. doi: 10.1038/s41598-023-42720-y.

DOI:10.1038/s41598-023-42720-y
PMID:37726320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10509172/
Abstract

Major depressive disorder (MDD) is a common and socially burdensome psychiatric disorder with a causal and complex relationship with metabolic syndrome (MetS), which is often co-morbid. However, the prevalence and risk factors for MetS in patients with MDD are inconclusive. The purpose of this study is to investigate the prevalence and factors influencing MetS in first hospitalization MDD patients. A total of 981 MDD patients were included. Sociodemographic and general clinical data were collected from the patients, while metabolism-related parameters were also measured, and psychological symptoms were assessed. Our study found that the prevalence of MetS in the study population was 9.68%. MDD patients with MetS had higher levels of metabolism-related parameters and more severe psychological symptoms. We identified risk factors for MetS and its severity separately: age of onset of MDD, more severe depressive symptoms, and higher thyroid stimulating hormone (TSH) levels were risk factors for the development of MetS, whereas higher TSH levels were risk factors for the severity of MetS. Our results suggest that MetS is not highly prevalent in MDD patients, but certain risk factors may increase its likelihood and severity, and that these findings could be beneficial for clinical intervention and care of MetS.

摘要

重度抑郁症(MDD)是一种常见的、给社会带来沉重负担的精神疾病,它与代谢综合征(MetS)有着因果关系和复杂的关系,且常常并发。然而,MDD 患者代谢综合征的患病率和危险因素尚无定论。本研究旨在探讨首次住院 MDD 患者代谢综合征的患病率及影响因素。共纳入 981 例 MDD 患者。从患者那里收集人口统计学和一般临床数据,同时测量与代谢相关的参数,并评估心理症状。我们的研究发现,该研究人群中代谢综合征的患病率为 9.68%。患有代谢综合征的 MDD 患者的代谢相关参数水平更高,心理症状更严重。我们分别确定了代谢综合征及其严重程度的危险因素:MDD 的发病年龄、更严重的抑郁症状和更高的促甲状腺激素(TSH)水平是代谢综合征发展的危险因素,而更高的 TSH 水平是代谢综合征严重程度的危险因素。我们的研究结果表明,代谢综合征在 MDD 患者中并不高发,但某些危险因素可能会增加其发生和严重程度,这些发现有助于代谢综合征的临床干预和护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fb/10509172/c817fceb8753/41598_2023_42720_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fb/10509172/c817fceb8753/41598_2023_42720_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0fb/10509172/c817fceb8753/41598_2023_42720_Fig1_HTML.jpg

相似文献

1
Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients.首发重性抑郁障碍患者住院期间代谢综合征的患病率及相关因素分析。
Sci Rep. 2023 Sep 19;13(1):15496. doi: 10.1038/s41598-023-42720-y.
2
Elevated thyroid stimulating hormone and metabolic syndrome risk in patients with first-episode and drug-naïve major depressive disorder: a large-scale cross-sectional study.首发未用药的重性抑郁障碍患者甲状腺刺激激素升高与代谢综合征风险:一项大规模横断面研究。
BMC Psychiatry. 2024 May 21;24(1):380. doi: 10.1186/s12888-024-05847-4.
3
Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome.首发未用药的伴代谢综合征的重性抑郁障碍患者中,焦虑的性别差异及其与临床的相关性。
BMC Psychiatry. 2024 Feb 22;24(1):156. doi: 10.1186/s12888-024-05574-w.
4
Clinical correlates and thyroid hormones of metabolic syndrome in first-episode and drug-naïve major depressive disorder outpatients with and without hyperglycemia: a comprehensive cross-sectional study.首发未用药的伴或不伴高血糖的成年抑郁症患者代谢综合征的临床相关因素及甲状腺激素:一项全面的横断面研究。
BMC Psychiatry. 2023 Sep 4;23(1):649. doi: 10.1186/s12888-023-05150-8.
5
Association of subclinical hypothyroidism with metabolic syndrome and its components among outpatients with first-episode drug-naïve major depressive disorder: a large-scale cross-sectional study.亚临床甲状腺功能减退与首发未经药物治疗的单相重性抑郁障碍门诊患者代谢综合征及其组份的相关性:一项大规模的横断面研究。
Eur Arch Psychiatry Clin Neurosci. 2024 Apr;274(3):573-582. doi: 10.1007/s00406-023-01588-9. Epub 2023 Mar 24.
6
Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome.代谢综合征首发未用药的重性抑郁障碍患者甲状腺功能障碍的流行率及临床相关因素。
J Affect Disord. 2023 Nov 15;341:35-41. doi: 10.1016/j.jad.2023.08.103. Epub 2023 Aug 24.
7
Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls.双相情感障碍患者的代谢综合征:与重度抑郁症和非精神科对照的比较。
J Psychosom Res. 2015 Apr;78(4):391-8. doi: 10.1016/j.jpsychores.2015.02.010. Epub 2015 Feb 25.
8
Gender Differences in the Prevalence and Clinical Correlates of Metabolic Syndrome in First-Episode and Drug-Naïve Patients With Major Depressive Disorder.首发且未用药的重性抑郁障碍患者中代谢综合征的流行率及其与临床指标的相关性的性别差异。
Psychosom Med. 2024 Apr 1;86(3):202-209. doi: 10.1097/PSY.0000000000001293. Epub 2024 Feb 28.
9
Identifying influencing factors of metabolic syndrome in patients with major depressive disorder: A real-world study with Bayesian network modeling.识别伴发于重度抑郁症患者的代谢综合征的影响因素:基于贝叶斯网络建模的真实世界研究。
J Affect Disord. 2024 Oct 1;362:308-316. doi: 10.1016/j.jad.2024.07.004. Epub 2024 Jul 4.
10
The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety.首发未用药的伴发焦虑的单相重性抑郁障碍门诊患者中代谢综合征的流行情况及其相关因素。
Sci Rep. 2021 Feb 8;11(1):3324. doi: 10.1038/s41598-021-81653-2.

引用本文的文献

1
Could thyrotropin serum level characterize major depressive disorder phenotype? A systematic review and meta-analysis.促甲状腺激素血清水平能否表征重度抑郁症的表型?一项系统评价与荟萃分析。
J Endocrinol Invest. 2025 Aug 19. doi: 10.1007/s40618-025-02687-1.
2
Branched-chain amino acids and risk of major depressive disorder: a Mendelian randomization and colocalization study.支链氨基酸与重度抑郁症风险:一项孟德尔随机化和共定位研究
Psychopharmacology (Berl). 2025 Jul 15. doi: 10.1007/s00213-025-06851-6.
3
Metabolic syndrome patterns by gender in major depressive disorder.

本文引用的文献

1
Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients.初治及未用药精神分裂症患者代谢综合征患病率及相关因素的性别差异
Ann Gen Psychiatry. 2023 Jun 28;22(1):25. doi: 10.1186/s12991-023-00455-0.
2
The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights.微生物群-肠道-大脑轴:心理神经免疫学的新见解。
Nutrients. 2023 Mar 20;15(6):1496. doi: 10.3390/nu15061496.
3
Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses.
重度抑郁症中按性别划分的代谢综合征模式。
PLoS One. 2024 Dec 4;19(12):e0313629. doi: 10.1371/journal.pone.0313629. eCollection 2024.
首发未经治疗的中国重度抑郁症患者甲状腺功能障碍、代谢紊乱与临床症状的关系:无向和贝叶斯网络分析。
Front Endocrinol (Lausanne). 2023 Feb 28;14:1138233. doi: 10.3389/fendo.2023.1138233. eCollection 2023.
4
Association of metabolic syndrome and its components with the risk of depressive symptoms: A systematic review and meta-analysis of cohort studies.代谢综合征及其组分与抑郁症状风险的关联:队列研究的系统评价和荟萃分析。
J Affect Disord. 2023 Feb 15;323:46-54. doi: 10.1016/j.jad.2022.11.049. Epub 2022 Nov 24.
5
Major Depression and Its Recurrences: Life Course Matters.重度抑郁症及其复发:生命历程至关重要。
Annu Rev Clin Psychol. 2022 May 9;18:329-357. doi: 10.1146/annurev-clinpsy-072220-021440. Epub 2022 Feb 25.
6
The Racial Disparities in the Epidemic of Metabolic Syndrome With Increased Age: A Study From 28,049 Chinese and American Adults.种族差异与代谢综合征流行:一项来自 28049 名中国和美国成年人的研究。
Front Public Health. 2022 Feb 1;9:797183. doi: 10.3389/fpubh.2021.797183. eCollection 2021.
7
Prevalence and Influencing Factors of Metabolic Syndrome among Adults in China from 2015 to 2017.2015 年至 2017 年中国成年人代谢综合征的患病率及影响因素。
Nutrients. 2021 Dec 15;13(12):4475. doi: 10.3390/nu13124475.
8
Metabolic syndrome components and leukocyte telomere length in patients with major depressive disorder.代谢综合征成分与重度抑郁症患者白细胞端粒长度的关系。
World J Biol Psychiatry. 2022 Jul;23(6):483-492. doi: 10.1080/15622975.2021.2013091. Epub 2021 Dec 16.
9
Predictive value of cardiometabolic biomarkers and depressive symptoms for symptom severity and quality of life in patients with psychotic disorders.代谢相关心血管生物标志物和抑郁症状对精神病患者症状严重程度和生活质量的预测价值。
J Affect Disord. 2022 Feb 1;298(Pt A):95-103. doi: 10.1016/j.jad.2021.10.038. Epub 2021 Oct 24.
10
Metabolic syndrome severity score and the progression of CKD.代谢综合征严重程度评分与慢性肾脏病的进展
Eur J Clin Invest. 2022 Jan;52(1):e13646. doi: 10.1111/eci.13646. Epub 2021 Jul 13.